Preparation of vaccine for children below 12 years, Pfizer company starts clinical trial

Pfizer said on Tuesday that it will begin testing its COVID-19 vaccine on a large group of children under the age of 12 after selecting a low dose of the shot in the first phase of testing. 4,500 children have been enrolled in 90 locations in some countries for the trial.